Abstract
Postural tachycardia syndrome (PoTS) is neither a mental health disorder nor is it caused by mental health issues. Nonetheless, like all health conditions, mental health difficulties can negatively impact on outcomes in PoTS. Anxiety and mood disturbances can be precipitated by the symptom burden, and may exacerbate symptoms thereafter if not well managed. Clearly, there are significant quality of life (QoL) impacts for people with PoTS to adjust to. There is some controversy about whether mood and anxiety disorders are more common in those with PoTS. Review of the literature suggests that mood challenges in PoTS are equivalent to other health disorders with equivalent magnitude of symptom burden and disability. The anxiety seen in PoTS patients seems to take a specific form and be somatically and attentionally based, rather than cognitive. Indeed, PoTS is associated with evidence of sympathetic dysregulation with symptoms overlapping with somatic aspects of anxiety. This can easily be mistaken for anxiety by observers, or misinterpreted as threatening or scary by the patient; thereafter initiating or exacerbating an anxious response cycle. Effective management therefore requires a balance of symptom monitoring and acceptance/tolerance of the symptoms. Over-attending can easily tip over into hyper-vigilance, which can cause an anxiety disorder. Conversely, and quite commonly in clinical practice, patients can present with dissociative coping strategies to avoid unpleasant sensations and emotions. There is also some evidence that PoTS compromises cognitive functioning, which can be distressing for patients and potentially affect their ability to engage in daily educational and occupational activities. PoTS patients often have a history of pushing through pain or discomfort to get on and achieve what they need to. This can result in a ‘boom and bust’ profile, and possibly syncope (where physical pre-syncopal cues are tuned out as well as other PoTS symptoms). Conversely, some patients with PoTS are so adept at compensating for autonomic dysregulation that they are less likely to faint than the general population. Since PoTS has a unique thumbprint in each patient, generalizations must be made with caution. Review of the psychological data suggests, however, that most patients would benefit from high quality and timely support to help them manage this challenging condition, and in this chapter we suggest therapeutic considerations and approaches for interested clinicians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, Haythornthwaite JA, Low PA. Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77(6):531–7.
McDonald C, Koshi S, Busner L, Kavi L, Newton JL. Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective. BMJ Open. 2014;4(6):e004127.
Moon J, Kim DY, Byun JI, Sunwoo JS, Lim JA, Kim TJ, et al. Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Health Qual Life Outcomes. 2016;14(1):144.
Pederson CL, Brook JB. Health-related quality of life and suicide risk in postural tachycardia syndrome. Clin Auton Res. 2017;27(2):75–81.
Kavi LN M, Low DA, Opie M, Nicholson LM, Caldow E, Newton JL. A profile of patients with postural tachycardia syndrome and their experience of healthcare in the UK. Br J Cardiol. 2016;23:33.
Pederson CL, Blettner BJ. Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome. Nat Sci Sleep. 2017;9:109–15.
Anderson JW, Lambert EA, Sari CI, Dawood T, Esler MD, Vaddadi G, et al. Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol. 2014;5:230.
Mindfulness All-Party Parliamentary Group. Mindful Nation UK. 2015; Available from: https://themindfulnessinitiative.org.uk/images/reports/Mindfulness-APPG-Report_Mindful-Nation-UK_Oct2015.pdf.
Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117(21):2814–7.
Department of Health. Psychological assessment and treatment for medically unexplained symptoms and long-term conditions. 2009; Available from: https://arms.evidence.nhs.uk/resources/qipp/29417/attachment.
McGrady A, Kern-Buell C, Bush E, Khuder S, Grubb BP. Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. Pacing Clin Electrophysiol. 2001;24(3):296–301.
Raj V, Haman KL, Raj SR, Byrne D, Blakely RD, Biaggioni I, et al. Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry. 2009;80(3):339–44.
Khurana RK. Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome. Clin Auton Res. 2006;16(6):371–7.
Masuki S, Eisenach JH, Johnson CP, Dietz NM, Benrud-Larson LM, Schrage WG, et al. Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. J Appl Physiol (1985). 2007; 102(3):896–903.
Ross AJ, Medow MS, Rowe PC, Stewart JM. What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res. 2013;23(6):305–11.
Arnold AC, Haman K, Garland EM, Raj V, Dupont WD, Biaggioni I, et al. Cognitive dysfunction in postural tachycardia syndrome. Clin Sci (Lond). 2015;128(1):39–45.
Ocon AJ, Messer ZR, Medow MS, Stewart JM. Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin Sci (Lond). 2012;122(5):227–38.
Stewart JM, Medow MS, Messer ZR, Baugham IL, Terilli C, Ocon AJ. Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2012;302(5):H1185–94.
Stewart JM, Del Pozzi AT, Pandey A, Messer ZR, Terilli C, Medow MS. Oscillatory cerebral blood flow is associated with impaired neurocognition and functional hyperemia in postural tachycardia syndrome during graded tilt. Hypertension. 2015;65(3):636–43.
Raj V, Opie M, Arnold AC. Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci. 2018;215:46–55.
Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011;93(3):385–404.
Dubey DH S, Vernino S. M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis. 2016; 17(3):179.
Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, Dumitrascu DL. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry. 2014;2(1):4.
Baeza-Velasco C, Bourdon C, Polanco-Carrasco R, de Jouvencel M, Gely-Nargeot MC, Gompel A, et al. Cognitive impairment in women with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type. Rheumatol Int. 2017;37(6):937–9.
Bagai K, Song Y, Ling JF, Malow B, Black BK, Biaggioni I, et al. Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med . 2011;7(2):204–10.
Mallien J, Isenmann S, Mrazek A, Haensch CA. Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome. Front Neurol. 2014;5:118.
Miglis MG, Barwick F. Sleep disorders in patients with postural tachycardia syndrome: A review of the literature and guide for clinicians. Auton Neurosci. 2018;215:62–9.
Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et al. The face of postural tachycardia syndrome—insights from a large cross-sectional online community-based survey. J Intern Med. 2019.
Office of National Statistics. Crime in England and Wales. 2016; Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/bulletins/crimeinenglandandwales/yearendingmar2016.
Smith SM, Sonego S, Ketcheson L, Larson JL. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014;1(1):e000042.
Gotink RA, Chu P, Busschbach JJ, Benson H, Fricchione GL, Hunink MG. Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs. PLoS ONE. 2015;10(4):e0124344.
Zeidan F, Johnson SK, Gordon NS, Goolkasian P. Effects of brief and sham mindfulness meditation on mood and cardiovascular variables. J Altern Complement Med. 2010;16(8):867–73.
Garland EL, Gaylord SA, Palsson O, Faurot K, Douglas Mann J, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med. 2012;35(6):591–602.
Vujanovic AA, Zvolensky MJ, Bernstein A, Feldner MT, McLeish AC. A test of the interactive effects of anxiety sensitivity and mindfulness in the prediction of anxious arousal, agoraphobic cognitions, and body vigilance. Behav Res Ther. 2007;45(6):1393–400.
Nyklicek I, Mommersteeg PM, Van Beugen S, Ramakers C, Van Boxtel GJ. Mindfulness-based stress reduction and physiological activity during acute stress: a randomized controlled trial. Health Psychol. 2013;32(10):1110–3.
Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, et al. Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome. J Intern Med. 2017;281(2):179–88.
Freedenberg VA, Hinds PS, Friedmann E. Mindfulness-based stress reduction and group support decrease stress in adolescents with cardiac diagnoses: a randomized two-group study. Pediatr Cardiol. 2017.
Hawton A, Green C, Dickens AP, Richards SH, Taylor RS, Edwards R, et al. The impact of social isolation on the health status and health-related quality of life of older people. Qual Life Res. 2011;20(1):57–67.
Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137(2):158–64.
Ralston TE, Kanzler KE. Symptom discrimination and habituation: a case study of behavioral treatment for Postural Orthostatic Tachycardia Syndrome (POTS). Behav Med. 2016;42(1):57–62.
Harris R. ACT made simple: an easy-to-read primer on acceptance and commitment therapy Oakland. CA: New Harbinger; 2009.
JG AT, Davis ML, Morina N, Powers MB, Smits JA, Emmelkamp PM. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30–6.
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the s. Arch Gen Psychiatry. 2005;62(6):617–27.
Mar PL, Raj V, Black BK, Biaggioni I, Shibao CA, Paranjape SY, et al. Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial. J Psychopharmacol. 2014;28(2):155–61.
Blier P. Neurobiology of depression and mechanism of action of depression treatments. J Clin Psychiatry. 2016;77(3):e319.
Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD, et al. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013;2(5):e000395.
Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix
Summary of Mental Health Recommendations in PoTS
Patients with PoTS are at risk of experiencing at least modest depressive and anxiety symptoms, and are at significantly increased risk of experiencing insomnia and suicidal ideation. They warrant and should have access to mental health assessment, treatment and support. We would advocate that:
-
Given the likelihood of patients being referred to mental health professionals, they and allied disciplines should be educated about PoTS and how to refer appropriately if they suspect it.
-
Most patients with long-term conditions would benefit from, and all should have ready access on request, to psychological support.
-
Introducing this support as early as possible is likely to be a very important factor in preventing QoL deterioration and associated secondary factors such as reactive depression, avoidance and physical deconditioning.
-
Uptake and engagement is likely to be increased if therapeutic support is offered as part of standard treatment and is seen as endorsed by a medical consultant active in the patient’s care.
-
CBT has a good evidence base in LTCs assuming a patient is motivated and has cognitive capacity.
-
Evidence supporting the value of Mindfulness-based CBT and ACT in the context of chronic illness is increasing.
-
These ‘third wave’ CBT approaches are likely to be helpful in appropriately modifying vigilance to somatic changes, and tolerating the frustrations that come with ill-health, while continuing to engage in manageable activities which enhance QoL.
-
Therapists with a good understanding of supporting patients with chronic health issues, and experience with formulating and treatment in the context of multiple co-morbidities, are most likely to benefit patients.
-
It can be very challenging making all the necessary life adaptations to live with PoTS. It can help patients to know that after the hard work of adjusting to what they cannot do and prioritizing and appreciating what they can do, many patients with PoTS report enjoying happy and fulfilling lives.
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Opie, M., Raj, V., Arnold, A.C. (2021). Psychological and Psychiatric Support; When, Why and What to Do. In: Gall, N., Kavi, L., Lobo, M.D. (eds) Postural Tachycardia Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-54165-1_40
Download citation
DOI: https://doi.org/10.1007/978-3-030-54165-1_40
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54164-4
Online ISBN: 978-3-030-54165-1
eBook Packages: MedicineMedicine (R0)